Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
2,168.00
+28.00 (1.31%)
Jul 14, 2026, 3:30 PM JST
TYO:4538 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
Cash & Equivalents | 4,846 | 6,264 | 5,120 | 9,120 | 4,278 |
Cash & Short-Term Investments | 4,846 | 6,264 | 5,120 | 9,120 | 4,278 |
Cash Growth | -22.64% | 22.34% | -43.86% | 113.18% | 11.61% |
Receivables | 26,897 | 26,491 | 24,328 | 22,613 | 19,442 |
Inventory | 15,682 | 14,941 | 14,202 | 8,247 | 7,345 |
Prepaid Expenses | 331 | 275 | 275 | - | - |
Other Current Assets | 9,580 | 371 | 1,022 | 166 | 299 |
Total Current Assets | 57,336 | 48,342 | 44,947 | 40,893 | 32,114 |
Property, Plant & Equipment | 22,185 | 23,110 | 24,424 | 22,490 | 23,717 |
Long-Term Investments | 5,332 | 4,375 | 3,924 | 8,067 | 5,499 |
Other Intangible Assets | 1,352 | 1,513 | 600 | 376 | 166 |
Long-Term Deferred Tax Assets | 2,572 | 296 | 396 | - | - |
Other Long-Term Assets | 1,546 | 1,417 | 1,511 | 3 | 2 |
Total Assets | 90,323 | 79,053 | 75,802 | 71,849 | 61,528 |
Accounts Payable | 4,067 | 3,998 | 7,352 | 12,178 | 11,347 |
Accrued Expenses | 1,724 | 1,765 | 1,318 | 996 | 809 |
Short-Term Debt | 29,012 | 22,630 | 12,413 | 6,920 | 6,713 |
Current Portion of Long-Term Debt | 604 | 827 | 3,351 | 100 | 100 |
Current Portion of Leases | - | - | - | 2 | 1 |
Current Income Taxes Payable | 103 | 949 | 270 | 3,606 | 1,595 |
Other Current Liabilities | 16,174 | 5,218 | 4,946 | 3,733 | 3,707 |
Total Current Liabilities | 51,684 | 35,387 | 29,650 | 27,535 | 24,272 |
Long-Term Debt | 1,858 | 2,462 | 7,021 | 6,191 | 6,679 |
Long-Term Leases | - | - | - | 4 | - |
Pension & Post-Retirement Benefits | 177 | 506 | 889 | 1,577 | 1,488 |
Long-Term Deferred Tax Liabilities | 1,354 | 1,315 | 1,315 | 2,750 | 2,208 |
Other Long-Term Liabilities | 193 | 272 | 266 | 695 | 282 |
Total Liabilities | 55,266 | 39,942 | 39,141 | 38,752 | 34,929 |
Common Stock | 10,758 | 10,758 | 10,758 | 10,758 | 10,758 |
Additional Paid-In Capital | 14,951 | 14,951 | 14,951 | 15,010 | 15,010 |
Retained Earnings | 13,881 | 18,680 | 16,541 | 10,841 | 6,201 |
Treasury Stock | -2,595 | -2,593 | -2,588 | -1,414 | -1,409 |
Comprehensive Income & Other | -1,938 | -2,685 | -3,001 | -2,098 | -3,961 |
Shareholders' Equity | 35,057 | 39,111 | 36,661 | 33,097 | 26,599 |
Total Liabilities & Equity | 90,323 | 79,053 | 75,802 | 71,849 | 61,528 |
Total Debt | 31,474 | 25,919 | 22,785 | 13,217 | 13,493 |
Net Cash (Debt) | -26,628 | -19,655 | -17,665 | -4,097 | -9,215 |
Net Cash Per Share | -3118.54 | -2300.83 | -2051.55 | -452.52 | -1017.64 |
Filing Date Shares Outstanding | 8.54 | 8.54 | 8.61 | 9.05 | 9.05 |
Total Common Shares Outstanding | 8.54 | 8.54 | 8.61 | 9.05 | 9.05 |
Working Capital | 5,652 | 12,955 | 15,297 | 13,358 | 7,842 |
Book Value Per Share | 4106.45 | 4579.55 | 4257.67 | 3656.06 | 2937.67 |
Tangible Book Value | 33,705 | 37,598 | 36,061 | 32,721 | 26,433 |
Tangible Book Value Per Share | 3948.08 | 4402.39 | 4187.99 | 3614.52 | 2919.33 |
Land | 8,820 | 8,818 | 8,818 | - | - |
Buildings | 34,918 | 34,746 | 34,599 | - | - |
Machinery | 34,866 | 34,521 | 33,985 | - | - |
Construction In Progress | 616 | 174 | 246 | - | - |